Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × Motivational Interviewing × Clear all

Phase

Status

Completed 19 Unknown 6 Not yet recruiting 3 Active not recruiting 3 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Patient Compliance 1 Breast Neoplasms 1

Interventions

pembrolizumab 559 Specimen Handling 455 Carboplatin 444 Magnetic Resonance Spectroscopy 421 Cisplatin 400 Cyclophosphamide 398 Radiotherapy 316 Gemcitabine 311 Bevacizumab 306 Paclitaxel 297 Biopsy 255 Drug Therapy 250 venetoclax 228 Nivolumab 227 Capecitabine 226 Oxaliplatin 225 fludarabine 222 Injections 211 Docetaxel 203 Fluorouracil 195 Dexamethasone 189 Radiosurgery 165 Rituximab 160 Pemetrexed 158 Standard of Care 146 durvalumab 144 atezolizumab 141 130-nm albumin-bound paclitaxel 135 Leucovorin 133 Etoposide 133

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06635005 2025-10-16

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡